CN115944707A - Composition for reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof - Google Patents
Composition for reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof Download PDFInfo
- Publication number
- CN115944707A CN115944707A CN202310090587.9A CN202310090587A CN115944707A CN 115944707 A CN115944707 A CN 115944707A CN 202310090587 A CN202310090587 A CN 202310090587A CN 115944707 A CN115944707 A CN 115944707A
- Authority
- CN
- China
- Prior art keywords
- parts
- plate
- material pushing
- driving shaft
- pushing plate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 43
- 239000008280 blood Substances 0.000 title claims abstract description 40
- 210000004369 blood Anatomy 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 150000002632 lipids Chemical class 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 102
- 238000002156 mixing Methods 0.000 claims abstract description 64
- 239000000284 extract Substances 0.000 claims abstract description 47
- 240000000249 Morus alba Species 0.000 claims abstract description 13
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 13
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 12
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 10
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 10
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 6
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 6
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 6
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 6
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 6
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 6
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 6
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 6
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 6
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 6
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 6
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 3
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 3
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 28
- 201000001421 hyperglycemia Diseases 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 8
- 238000013016 damping Methods 0.000 claims description 7
- 235000013339 cereals Nutrition 0.000 claims description 6
- 235000020717 hawthorn extract Nutrition 0.000 claims description 6
- 235000007319 Avena orientalis Nutrition 0.000 claims description 3
- 241000209763 Avena sativa Species 0.000 claims description 3
- 235000007558 Avena sp Nutrition 0.000 claims description 3
- 244000077995 Coix lacryma jobi Species 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 244000017020 Ipomoea batatas Species 0.000 claims description 3
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 244000062793 Sorghum vulgare Species 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 235000005822 corn Nutrition 0.000 claims description 3
- 235000019713 millet Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 235000020183 skimmed milk Nutrition 0.000 claims description 3
- 240000008866 Ziziphus nummularia Species 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 4
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 13
- 238000007790 scraping Methods 0.000 description 8
- 241000208340 Araliaceae Species 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 230000036039 immunity Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241001092040 Crataegus Species 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000243684 Lumbricus Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Mixers With Rotating Receptacles And Mixers With Vibration Mechanisms (AREA)
Abstract
The invention relates to the field of health-preserving foods, and in particular relates to a composition for reducing high blood pressure, high blood lipid and high blood sugar and a preparation method thereof. The composition comprises, by weight, 5 to 10 parts of mulberry leaf extract, 9 to 12 parts of hawthorn fruit extract, 10 to 15 parts of kudzu root extract, 10 to 15 parts of spina date seed extract, 5 to 10 parts of earthworm protein, 2 to 5 parts of ginseng, 9 to 15 parts of rhizoma polygonati and 1.5 to 5 parts of chitosan oligosaccharide. The preparation method comprises pulverizing the above materials, and mixing with a mixing device. It helps to keep the stability of the state of the disease of the three-high, reduce the incidence of the disease and laterally reduce the dependence of the three-high patients on the medicine.
Description
Technical Field
The invention relates to the field of health-preserving foods, and particularly relates to a composition for reducing high blood pressure, high blood lipid and high blood sugar and a preparation method thereof.
Background
For people with high blood pressure, high blood sugar and high blood sugar, the main means for reducing high blood pressure, high blood sugar and high blood sugar is still to take medicines. For the chronic disease of three highs, a certain influence on the body is bound to be generated by taking a large amount of medicine for a long time. For patients in the stable period of the disease, the dependence on the medicine is greatly reduced. During this period, if a certain diet therapy can be supplemented, the health-care food can help to keep the state of illness stable and reduce the incidence of illness.
In view of this, the present application is specifically proposed.
Disclosure of Invention
The first purpose of the invention is to provide a composition for reducing hypertension, hyperglycemia and hyperlipidemia, which is helpful for keeping the state of hypertension, hyperglycemia and hyperlipidemia stable, reducing the incidence probability and laterally reducing the dependence of patients with hypertension, hyperglycemia and hyperlipidemia on medicines.
The second purpose of the invention is to provide a preparation method of the composition for reducing hypertension, hyperglycemia and hyperlipidemia, which is simple, convenient to implement and apply.
The embodiment of the invention is realized by the following steps:
the composition for reducing high blood pressure, high blood lipid and high blood sugar comprises the following components in parts by weight: 5 to 10 parts of mulberry leaf extract, 9 to 12 parts of hawthorn fruit extract, 10 to 15 parts of kudzu root extract, 10 to 15 parts of spina date seed extract, 5 to 10 parts of earthworm protein, 2 to 5 parts of ginseng, 9 to 15 parts of rhizoma polygonati and 1.5 to 5 parts of chitosan oligosaccharide.
Further, the coating comprises the following components in parts by weight: 5 parts of mulberry leaf extract, 9 parts of hawthorn extract, 10 parts of kudzuvine root extract, 10 parts of spina date seed extract, 5 parts of earthworm protein, 2 parts of ginseng, 9 parts of rhizoma polygonati and 1.5 parts of chitosan oligosaccharide.
Further, the composition for reducing hypertension, hyperglycemia and hyperlipidemia comprises the following components in parts by weight: 10 to 15 parts of coarse cereals and 5 to 10 parts of skimmed milk powder.
Further, the coarse cereals comprise: at least one of corn, soybean, oat, coix seed, millet, sweet potato and polished round-grained rice.
Furthermore, the mulberry leaf extract, the hawthorn extract, the kudzu root extract and the spina date seed extract are all powder.
A preparation method of the composition for reducing hypertension, hyperglycemia and hyperlipidemia, which comprises the following steps: the components are crushed and then are mixed uniformly by a mixing device.
Further, the mixing device includes: mixing tank, drive shaft, connecting rod and scraping wings.
The bottom of blending tank is the arc, and the drive shaft sets up with the bottom of blending tank is coaxial. The connecting rod is fixedly connected to the driving shaft and arranged along the radial direction of the driving shaft, and the material pushing plate is fixedly connected to one end, far away from the driving shaft, of the connecting rod.
Wherein, the scraping wings are arranged in parallel with the axial lead of the driving shaft, and the scraping wings are arranged in parallel with the connecting rod. The distance from the end surface of one end of the material pushing plate far away from the connecting rod to the axial lead of the driving shaft is the same as the radius of the arc at the bottom of the mixing tank. The width of the material pushing plate is smaller than the width of the mixing tank in the axial direction of the driving shaft.
Furthermore, along the axial direction of the driving shaft, the edge parts of the two sides of the material pushing plate are provided with baffle plates which are fixedly connected with the same surface of the material pushing plate. The one end tip that the connecting rod was kept away from to the scraping wings is fixedly connected with guide board still, and the guide board is connected in the one side at baffle place, and the guide board is with the bottom arc looks adaptation of blending tank.
Further, the mixing device further comprises: backplate, control panel and guide rail.
The material passing opening is formed in the plate surface of the material pushing plate, and the back plate is hinged to the surface, far away from the baffle, of the material pushing plate and is close to the material passing opening so as to be used for sealing the material passing opening.
The control plate is hinged to the connecting rod and extends towards the material pushing plate from the driving shaft. The rotating axes of the back plate and the control plate are arranged along the axial direction of the driving shaft.
The control panel still is equipped with the synchronizing wheel, and the synchronizing wheel includes wheel body and outer loop, and the coaxial fixed connection of pivot of wheel body and control panel, wheel body is located to the outer loop cover, and the outer loop has damping ground normal running fit to take turns the body.
The guide rail is the arc, and guide rail and the coaxial setting of drive shaft, guide rail fixed connection are in the lateral wall of blending tank and are close to the drive shaft setting. The outer ring and the guide rail are in damping fit. The resistance between the outer ring and the guide rail is larger than the resistance between the outer ring and the wheel body, and the resistance between the outer ring and the wheel body is larger than the force required by the rotation of the driving control plate.
The back plate has a first rotation stop point and a second rotation stop point. When the back plate is positioned at the first rotation stop point, the back plate is attached to the material pushing plate and covers the material passing opening. When the back plate is positioned at the second rotation stop point, one end of the back plate close to the connecting rod is opened, and an included angle of 45 degrees is formed between the back plate and the material pushing plate.
The control plate has a third rotation stop and a fourth rotation stop. When the control panel is located the third rotation stop, the control panel is on a parallel with the scraping wings, one end of the control panel extends to the driving shaft, and the other end extends to the scraping wings and is attached to the back plate, so that the back plate is abutted to the first rotation stop. When the control panel is located the fourth rotation stop, the backplate is kept away from to the one end that the control panel is close to the scraping wings, and is 30 contained angles between control panel and the scraping wings.
Wherein the guide rail is configured to: when the material pushing plate is driven by the driving shaft to rotate towards the top of the mixing tank and the material pushing plate is about to rotate to be horizontal, the outer ring of the synchronizing wheel is in contact with the rail surface of the guide rail, and the synchronizing wheel rotates under the damping of the guide rail to enable the control plate to return to the third rotation dead point from the fourth rotation dead point. As the drive shaft continues to rotate, the synchronizing wheel moves along the guide rail and the outer ring rotates relative to the wheel body. When the material pushing plate rotates upwards to exceed the top dead center, the synchronizing wheel is separated from the guide rail.
Furthermore, the connecting rod is positioned at the edge part of one side of the material pushing plate, which is far away from the guide rail.
The technical scheme of the embodiment of the invention has the beneficial effects that:
the components of the composition for reducing the three-high blood pressure, the blood sugar and the blood sugar supplement each other, can effectively improve the symptoms of people with the three-high blood pressure, and has the effect of assisting in reducing the three-high blood pressure.
For patients with stable disease conditions or in a stable period, the composition is supplemented with diet therapy, so that the stability of the three-high disease can be further improved, the stability of the three-high disease is maintained, the morbidity probability is reduced, the self-regulation capability of the body is improved, and the high dependence of the three-high disease on medicines is reduced to a certain extent.
In general, the three-high reducing composition provided by the embodiment of the invention helps to keep the stability of the three-high state, reduces the incidence probability and laterally reduces the dependence of the three-high patient on drugs. The preparation method of the composition for reducing the hypertension, hyperglycemia and hyperlipidemia provided by the embodiment of the invention is simple, convenient and fast, and convenient to implement and apply.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required in the embodiments will be briefly described below, it should be understood that the following drawings only illustrate some embodiments of the present invention and therefore should not be considered as limiting the scope, and those skilled in the art can also obtain other related drawings based on the drawings without inventive efforts.
Fig. 1 is a schematic structural diagram of a first view angle of a mixing device used in a method for preparing a composition for reducing hypertension, hyperglycemia and hyperlipidemia according to an embodiment of the present invention;
fig. 2 is a schematic structural diagram of a second viewing angle of a mixing device used in a method for preparing a composition for reducing hypertension, hyperglycemia and hyperlipidemia according to an embodiment of the present invention;
FIG. 3 is an enlarged view of a portion of the ejector plate of FIG. 1;
FIG. 4 is a schematic view of a first working state of a material pushing plate of the mixing device when pushing the material;
FIG. 5 is a schematic view of a second working state of the ejector plate of the mixing device when pushing the material (the synchronizing wheel is in contact with the guide rail);
FIG. 6 is an enlarged view of a portion of the track and synchronizing wheel of FIG. 5;
fig. 7 is a schematic view of a third working state of the material pushing plate of the mixing device when pushing the material (the control plate returns to the third rotation endpoint, and the back plate returns to the first rotation endpoint);
FIG. 8 is a schematic view of a fourth operating state of the ejector plate of the mixing device when the material is pushed (the material flows along the ejector plate and the control plate to the other side of the driving shaft);
FIG. 9 is a schematic view of a fifth operating state of the ejector plate of the mixing device when the ejector plate pushes the material (the ejector plate goes beyond the top dead center, and the synchronizing wheel and the guide rail are about to separate);
fig. 10 is a schematic view of a sixth working state of the ejector plate of the mixing device when the material is pushed (the control plate and the back plate move downward along with the ejector plate).
Description of reference numerals:
a mixing device 1000; a mixing tank 100; a drive shaft 200; a connecting rod 210; a material pushing plate 300; a baffle 310; a guide plate 320; a material passing opening 330; a back plate 400; a control board 500; a synchronizing wheel 510; a wheel body 511; an outer ring 512; a guide rail 600.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are some, but not all, embodiments of the present invention. The components of embodiments of the present invention generally described and illustrated in the figures herein may be arranged and designed in a wide variety of different configurations.
Thus, the following detailed description of the embodiments of the present invention, as presented in the figures, is not intended to limit the scope of the invention, as claimed, but is merely representative of selected embodiments of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The examples, in which specific conditions are not specified, were carried out according to conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are conventional products which are not indicated by manufacturers and are commercially available.
It should be noted that: like reference numbers and letters refer to like items in the following figures, and thus, once an item is defined in one figure, it need not be further defined or explained in subsequent figures.
The terms "first," "second," "third," and the like are used solely to distinguish one from another and are not to be construed as indicating or implying relative importance.
Examples
The embodiment provides a composition for reducing hypertension, hyperglycemia and hyperlipidemia, which comprises the following components in parts by weight: 5 to 10 parts of mulberry leaf extract, 9 to 12 parts of hawthorn fruit extract, 10 to 15 parts of kudzu root extract, 10 to 15 parts of spina date seed extract, 5 to 10 parts of earthworm protein, 2 to 5 parts of ginseng, 9 to 15 parts of rhizoma polygonati and 1.5 to 5 parts of chitosan oligosaccharide.
The mulberry leaf extract has the effects of dispelling wind and heat, clearing lung, moistening dryness, clearing liver and improving eyesight, has the effects of resisting inflammation, reducing blood sugar, resisting oxidation, resisting stress, resisting fatigue and the like, and is beneficial to cardiovascular systems.
The fructus crataegi extract has effects of resolving food stagnation, invigorating stomach, activating qi-flowing, removing blood stasis, eliminating turbid pathogen, reducing blood lipid, regulating lipid, resisting myocardial ischemia, improving blood rheological property, regulating immunity, and resisting bacteria.
The radix Puerariae extract has effects of relieving muscles and fever, promoting fluid production to quench thirst, promoting eruption, invigorating yang and relieving diarrhea, dredging meridian passage, relieving fever, resisting oxidation, lowering blood sugar, resisting tumor, protecting liver, etc., and is beneficial to bone growth and cardiovascular system.
The semen Ziziphi Spinosae extract has effects of nourishing heart, nourishing liver, calming heart, tranquilizing mind, arresting sweating, promoting fluid production, tranquilizing mind, improving sleep, relieving depression, relieving convulsion, improving learning memory, relieving heart and cerebral ischemia, resisting anoxia, lowering blood pressure, reducing blood lipid, and enhancing immunity.
The Lumbricus protein has effects of clearing heat, arresting convulsion, dredging collaterals, relieving asthma, promoting urination, improving microcirculation, dissolving thrombi, softening blood vessel, reducing blood viscosity, regulating blood pressure, and reducing blood sugar.
Ginseng radix has effects of invigorating primordial qi, restoring pulse, relieving depletion, invigorating spleen, benefiting lung, promoting fluid production, nourishing blood, tranquilizing mind, improving intelligence, enhancing immunity, enhancing nonspecific resistance, resisting shock, myocardial ischemia, arrhythmia, promoting appetite box protein synthesis, promoting hematopoiesis, lowering blood sugar, improving memory, delaying aging, and resisting osteoporosis.
Rhizoma Polygonati has effects of invigorating qi, nourishing yin, invigorating spleen, moistening lung, invigorating kidney, enhancing immunity, relieving fatigue, improving memory, and resisting oxidation.
The chitosan oligosaccharide has the effects of immunoregulation, anti-tumor, blood fat reduction, blood sugar regulation, liver and heart and lung function improvement, intestinal microecology regulation, intestinal tissue morphology improvement, immunity enhancement and the like.
The components supplement each other, can effectively improve the symptoms of the crowd with high blood pressure, high blood sugar and high blood sugar, and has the effect of assisting in reducing high blood pressure, high blood sugar and high blood fat.
For patients with stable disease conditions or in a stable period, the composition is supplemented with diet therapy, so that the stability of the hypertension, hyperlipidemia and hyperglycemia can be further improved, the stability of the disease conditions of the hypertension, hyperlipidemia and hyperglycemia can be maintained, the morbidity probability is reduced, the self-regulation capability of the body is improved, and the high dependence of the hypertension, hyperlipidemia and hyperglycemia on medicines is reduced to a certain extent.
Optionally, the composition for reducing hypertension, hyperglycemia and hyperlipidemia may include, by weight: 5 parts of mulberry leaf extract, 9 parts of hawthorn extract, 10 parts of kudzuvine root extract, 10 parts of spina date seed extract, 5 parts of earthworm protein, 2 parts of ginseng, 9 parts of rhizoma polygonati and 1.5 parts of chitosan oligosaccharide.
Optionally, the composition for reducing hypertension, hyperglycemia and hyperlipidemia may include, by weight: 10 parts of mulberry leaf extract, 12 parts of hawthorn extract, 15 parts of kudzu root extract, 15 parts of spina date seed extract, 10 parts of earthworm protein, 5 parts of ginseng, 15 parts of rhizoma polygonati and 5 parts of chitosan oligosaccharide.
Optionally, the composition for reducing hypertension, hyperglycemia and hyperlipidemia may include, by weight: 8 parts of mulberry leaf extract, 10 parts of hawthorn extract, 12 parts of kudzuvine root extract, 12 parts of spina date seed extract, 8 parts of earthworm protein, 3 parts of ginseng, 10 parts of rhizoma polygonati and 2 parts of chitosan oligosaccharide.
Further, the three-high blood pressure reducing composition can also comprise the following components in parts by weight: 10 to 15 parts of coarse cereals and 5 to 10 parts of skimmed milk powder for seasoning and supplementing other nutrients. Wherein, the coarse cereals comprise: at least one of corn, soybean, oat, coix seed, millet, sweet potato and polished round-grained rice.
In this embodiment, the mulberry leaf extract, the hawthorn fruit extract, the kudzu root extract and the wild jujube seed extract are all in powder form. The powder may be prepared by freeze-drying folium Mori, fructus crataegi, radix Puerariae, and semen Ziziphi Spinosae, and pulverizing, but not limited thereto. Other forms of powdered extracts may also be used.
The present invention also provides a method for preparing the composition for reducing hypertension, hyperglycemia and hyperlipidemia, which comprises: the components are pulverized and then mixed uniformly by using a mixing device 1000.
For the mixing of powder products, the greater the amount mixed in a single mixing, the more likely it is that local inhomogeneities will occur, and in the packaging of the products, the greater the difference in the actual composition of the products in different packages may be.
In order to overcome the above drawbacks of the conventional mixing device, referring to fig. 1 to 3, this embodiment provides a mixing device 1000 specially used for the composition for reducing hypertension, hyperglycemia and hyperlipidemia.
Specifically, the mixing device 1000 includes: a mixing tank 100, a drive shaft 200, a connecting rod 210, and a stripper plate 300.
The bottom of the mixing tank 100 is arc-shaped, and the driving shaft 200 is coaxially arranged with the bottom of the mixing tank 100, that is, the cylinder corresponding to the arc surface of the bottom of the mixing tank 100 is coaxially arranged with the driving shaft 200.
The connecting rod 210 is fixedly coupled to the driving shaft 200 and is disposed in a radial direction of the driving shaft 200, and the ejector plate 300 is fixedly coupled to an end of the connecting rod 210 remote from the driving shaft 200. The ejector plate 300 is disposed parallel to the axial center line of the driving shaft 200, and the ejector plate 300 is disposed parallel to the connecting rod 210.
The distance from the end face of the ejector plate 300 far from the end face of the connecting rod 210 to the axial line of the driving shaft 200 is the same as the radius of the bottom arc of the mixing tank 100, that is, when the ejector plate 300 moves to the bottom of the mixing tank 100, the end of the ejector plate 300 far from the connecting rod 210 is attached to the bottom wall of the mixing tank 100.
The width of the ejector plate 300 is smaller than the width of the mixing tank 100 in the axial direction of the drive shaft 200, and the ejector plate 300 is located at the middle position of the mixing tank 100 in the axial direction of the drive shaft 200.
Through the design, in the mixing process, the driving shaft 200 drives the material pushing plate 300 to move, the material pushing plate 300 can fully push the material at the bottom of the mixing tank 100 and upwards push the material, the full mixing of the material in the whole mixing tank 100 is effectively promoted, and the overlarge local difference is avoided.
In addition, during the process of stirring the materials by the material pushing plate 300, the materials can cross the material pushing plate 300 from one end of the material pushing plate 300 close to the driving shaft 200, so that the resistance of the material pushing plate 300 during the process of stirring the materials is reduced, and the materials are promoted to flow fully and be homogenized in the mixing tank 100.
Referring to fig. 1 to 10, in the present embodiment, along the axial direction of the driving shaft 200, the two side edges of the material pushing plate 300 are provided with the baffle plates 310, and the baffle plates 310 are fixedly connected to the same surface of the material pushing plate 300. The end of the pusher plate 300 far from the connecting rod 210 is further fixedly connected with a guide plate 320, the guide plate 320 is connected to the surface where the baffle plate 310 is located, and the guide plate 320 is matched with the bottom arc of the mixing tank 100.
Wherein, mixing arrangement 1000 still includes: a back plate 400, a control board 500, and a guide rail 600.
The material passing opening 330 is opened on the plate surface of the material pushing plate 300, the back plate 400 is hinged to one surface of the material pushing plate 300 far away from the baffle 310 and is arranged close to the material passing opening 330, the back plate 400 is hinged to one side of the material passing opening 330 far away from the connecting rod 210, and the free end of the back plate 400 can rotate and be attached to the material passing opening 330 so as to seal the material passing opening 330.
The control plate 500 is hinged to the connecting rod 210, and the control plate 500 is extended toward the ejector plate 300 by the driving shaft 200. The rotational axes of both the back plate 400 and the control plate 500 are arranged in the axial direction of the drive shaft 200.
The control board 500 is further provided with a synchronizing wheel 510, the synchronizing wheel 510 comprises a wheel body 511 and an outer ring 512, the wheel body 511 is coaxially and fixedly connected with the rotating shaft of the control board 500, the outer ring 512 is sleeved on the wheel body 511, and the outer ring 512 is in damped rotation fit with the wheel body 511.
The guide rail 600 is arc-shaped, the guide rail 600 is coaxially disposed with the driving shaft 200, and the guide rail 600 is fixedly connected to the sidewall of the mixing tank 100 and disposed near the driving shaft 200. A damped fit is employed between outer ring 512 and rail 600. The resistance between the outer ring 512 and the guide rail 600 is greater than the resistance between the outer ring 512 and the wheel body 511, and the resistance between the outer ring 512 and the wheel body 511 is greater than the force required to drive the control plate 500 to rotate.
The back plate 400 has a first rotation stop point and a second rotation stop point. When the back plate 400 is located at the first rotation stop point, the back plate 400 is attached to the material pushing plate 300 and covers the material passing opening 330. When the back plate 400 is located at the second rotation stop point, one end of the back plate 400 close to the connecting rod 210 is opened, and an included angle of 45 degrees is formed between the back plate 400 and the material pushing plate 300.
The control plate 500 has a third rotation dead point and a fourth rotation dead point. When the control plate 500 is located at the third rotation stop point, the control plate 500 is parallel to the material pushing plate 300, one end of the control plate 500 extends to the driving shaft 200, and the other end extends to the material pushing plate 300 and is attached to the back plate 400, so that the back plate 400 is abutted against the first rotation stop point. When the control plate 500 is located at the fourth rotation stop point, one end of the control plate 500 close to the material pushing plate 300 is far away from the back plate 400, and an included angle of 30 degrees is formed between the control plate 500 and the material pushing plate 300.
When the materials are mixed, the materials in the mixing tank 100 are kept not to exceed the height of the driving shaft 200, and when the driving shaft 200 drives the material pushing plate 300 to stir the materials, under the reaction force of the materials, the back plate 400 rotates from the first rotation dead point to the second rotation dead point, the control plate 500 rotates from the third rotation dead point to the fourth rotation dead point, a part of the materials can pass through the material pushing plate 300 from the material passing opening 330, and a part of the materials can pass over the material pushing plate 300 from one end of the material pushing plate 300 close to the driving shaft 200, as shown in fig. 4. Not only improves the mixing effect, but also reduces the resistance borne by the material pushing plate 300.
Wherein the guide rail 600 is configured to: when the ejector plate 300 is rotated toward the top of the mixing pot 100 by the driving shaft 200, the outer ring 512 of the synchronizing wheel 510 is in contact with the rail surface of the guide rail 600 when the ejector plate 300 is about to rotate to the horizontal, as shown in fig. 5 and 6, and the connecting rod 210 drives the synchronizing wheel 510 of the control plate 500 to move along the surface of the guide rail 600 as the driving shaft 200 continues to drive.
Due to the damping fit between the surface of the guide rail 600 and the outer ring 512 of the synchronizing wheel 510, the surface of the guide rail 600 generates a resistance force to the outer ring 512, and the synchronizing wheel 510 rotates under the damping of the guide rail 600 to return the control plate 500 from the fourth rotation dead center to the third rotation dead center, as shown in fig. 7.
As the drive shaft 200 continues to rotate, the outer ring 512 rotates relative to the wheel body 511 to "advance" the sync wheel 510 along the track 600 because the control plate 500 cannot continue to rotate at this time and the resistance between the outer ring 512 and the track 600 is greater than the resistance between the outer ring 512 and the wheel body 511. In this state, the control board 500 is stably located at the third rotation stop point, and the back plate 400 is abutted by the control board 500 at the first rotation stop point.
In this state, the ejector plate 300 is continuously driven upward, and since the back plate 400 closes the material passing opening 330, the control plate 500 closes the gap between the driving shaft 200 and the ejector plate 300, and a part of the material is scooped up by the ejector plate 300 and the baffle plate 310.
As the ejector plate 300 continues to rotate upward, the end of the ejector plate 300 away from the driving shaft 200 is higher than the end thereof close to the driving shaft 200, and the material scooped up by the ejector plate 300 flows along the ejector plate 300 and the control plate 500 toward the driving shaft 200, and is guided from one side of the driving shaft 200 to the other side of the driving shaft 200, as shown in fig. 8. In this way, large-span mixing of the materials in the mixing tank 100 is achieved, and the probability of local obvious unevenness is further reduced.
After the pushing plate 300 continues to rotate upwards to go over the top dead center (highest position), as shown in fig. 9, the synchronizing wheel 510 is separated from the guide rail 600, and since the back plate 400 and the control plate 500 are both above the pushing plate 300 at this time, the back plate 400 and the control plate 500 will keep this state and continue to rotate along with the pushing plate 300, as shown in fig. 10, until the pushing plate 300 moves downwards again to push the material, and the control plate 500 and the back plate 400 will not reopen under the reaction force of boredom.
Through the design, the mixing effect in the mixing tank 100 is greatly improved, and the condition that the local part of the material is obviously uneven is effectively avoided.
In the present embodiment, the connecting rod 210 is located at an edge portion of the ejector plate 300 away from the guide rail 600.
In conclusion, the composition for reducing hypertension, hyperlipidemia and hyperglycemia provided by the embodiment of the invention is beneficial to maintaining the stability of the state of a patient with hypertension, hyperlipidemia and hyperglycemia, reducing the incidence probability and laterally reducing the dependence of the patient with hypertension, hyperlipidemia and hyperglycemia on medicines. The preparation method of the composition for reducing hypertension, hyperglycemia and hyperlipidemia provided by the embodiment of the invention is simple, convenient and fast, and convenient to implement and apply.
The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (10)
1. The composition for reducing high blood pressure, high blood lipid and high blood sugar is characterized by comprising the following components in parts by weight: 5 to 10 parts of mulberry leaf extract, 9 to 12 parts of hawthorn fruit extract, 10 to 15 parts of kudzu root extract, 10 to 15 parts of spina date seed extract, 5 to 10 parts of earthworm protein, 2 to 5 parts of ginseng, 9 to 15 parts of rhizoma polygonati and 1.5 to 5 parts of chitosan oligosaccharide.
2. The composition for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 1, comprises the following components in parts by weight: 5 parts of mulberry leaf extract, 9 parts of hawthorn extract, 10 parts of kudzuvine root extract, 10 parts of spina date seed extract, 5 parts of earthworm protein, 2 parts of ginseng, 9 parts of rhizoma polygonati and 1.5 parts of chitosan oligosaccharide.
3. The composition for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 1, further comprising, in parts by weight: 10 to 15 parts of coarse cereals and 5 to 10 parts of skimmed milk powder.
4. The composition for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 3, wherein the coarse cereals comprise: at least one of corn, soybean, oat, coix seed, millet, sweet potato and polished round-grained rice.
5. The composition for reducing high blood pressure, high blood lipid and high blood sugar of claim 1, wherein the mulberry leaf extract, the hawthorn fruit extract, the kudzuvine root extract and the wild jujube seed extract are all in powder form.
6. A preparation method of the composition for reducing hypertension, hyperglycemia and hyperlipidemia as claimed in any one of claims 1 to 5, wherein the preparation method comprises the following steps: the components are crushed and then are mixed uniformly by a mixing device.
7. The method for preparing the composition for reducing blood lipid and blood glucose as claimed in claim 6, wherein the mixing device comprises: the mixing tank, the driving shaft, the connecting rod and the material pushing plate;
the bottom of the mixing tank is arc-shaped, and the driving shaft and the bottom of the mixing tank are coaxially arranged; the connecting rod is fixedly connected to the driving shaft and arranged along the radial direction of the driving shaft, and the material pushing plate is fixedly connected to one end, far away from the driving shaft, of the connecting rod;
the material pushing plate is arranged in parallel to the axial lead of the driving shaft, and the material pushing plate is arranged in parallel to the connecting rod; the distance from the end face of one end of the material pushing plate, which is far away from the connecting rod, to the axial lead of the driving shaft is the same as the radius of the arc at the bottom of the mixing tank; the width of the material pushing plate is smaller than the width of the mixing tank in the axial direction of the driving shaft.
8. The method for preparing a composition for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 7, wherein baffles are arranged on two side edge portions of the material pushing plate along the axial direction of the driving shaft, and the baffles are fixedly connected to the same surface of the material pushing plate; the push plate is kept away from the end part of one end of the connecting rod is fixedly connected with a guide plate, the guide plate is connected to the surface where the baffle is located, and the guide plate is matched with the bottom arc of the mixing tank in an arc manner.
9. The method for preparing the composition for reducing blood lipid and blood glucose as claimed in claim 8, wherein the mixing device further comprises: the back plate, the control plate and the guide rail;
the surface of the material pushing plate is provided with a material passing hole, and the back plate is hinged to one surface of the material pushing plate, which is far away from the baffle and is close to the material passing hole, so that the material passing hole is sealed;
the control plate is hinged to the connecting rod and extends towards the material pushing plate from the driving shaft; the rotating shaft axes of the back plate and the control plate are arranged along the axial direction of the driving shaft;
the control panel is also provided with a synchronizing wheel, the synchronizing wheel comprises a wheel body and an outer ring, the wheel body is coaxially and fixedly connected with a rotating shaft of the control panel, the outer ring is sleeved on the wheel body, and the outer ring is in damped rotating fit with the wheel body;
the guide rail is arc-shaped, is coaxial with the driving shaft and is fixedly connected to the side wall of the mixing tank and is close to the driving shaft; the outer ring is in damping fit with the guide rail; the resistance between the outer ring and the guide rail is greater than the resistance between the outer ring and the wheel body, and the resistance between the outer ring and the wheel body is greater than the force required for driving the control plate to rotate;
the back plate is provided with a first rotation stop point and a second rotation stop point; when the back plate is positioned at the first rotation stop point, the back plate is attached to the material pushing plate and covers the material passing port; when the back plate is positioned at the second rotation stop point, one end of the back plate close to the connecting rod is opened, and an included angle of 45 degrees is formed between the back plate and the material pushing plate;
the control plate is provided with a third rotation stop point and a fourth rotation stop point; when the control plate is positioned at the third rotation stop point, the control plate is parallel to the material pushing plate, one end of the control plate extends to the driving shaft, and the other end of the control plate extends to the material pushing plate and is attached to the back plate, so that the back plate is abutted against the first rotation stop point; when the control plate is positioned at the fourth rotation stop point, one end, close to the material pushing plate, of the control plate is far away from the back plate, and an included angle of 30 degrees is formed between the control plate and the material pushing plate;
wherein the guide rail is configured to: when the material pushing plate rotates towards the top of the mixing tank under the driving of the driving shaft and the material pushing plate is about to rotate to be horizontal, the outer ring of the synchronizing wheel is in contact with the rail surface of the guide rail, and the synchronizing wheel rotates under the damping of the guide rail to enable the control plate to return to the third rotation dead point from the fourth rotation dead point; as the drive shaft continues to rotate, the synchronizing wheel moves along the guide rail, and the outer ring rotates relative to the wheel body; and when the material pushing plate rotates upwards to exceed the top dead center, the synchronizing wheel is separated from the guide rail.
10. The method for preparing a composition for reducing hypertension, hyperglycemia and hyperlipidemia according to claim 9, wherein the connecting rod is located at an edge portion of one side of the material pushing plate away from the guide rail.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410809372.2A CN118577160A (en) | 2023-02-09 | 2023-02-09 | Preparation method of composition for reducing three highs |
| CN202310090587.9A CN115944707A (en) | 2023-02-09 | 2023-02-09 | Composition for reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310090587.9A CN115944707A (en) | 2023-02-09 | 2023-02-09 | Composition for reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410809372.2A Division CN118577160A (en) | 2023-02-09 | 2023-02-09 | Preparation method of composition for reducing three highs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115944707A true CN115944707A (en) | 2023-04-11 |
Family
ID=87282689
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410809372.2A Pending CN118577160A (en) | 2023-02-09 | 2023-02-09 | Preparation method of composition for reducing three highs |
| CN202310090587.9A Pending CN115944707A (en) | 2023-02-09 | 2023-02-09 | Composition for reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410809372.2A Pending CN118577160A (en) | 2023-02-09 | 2023-02-09 | Preparation method of composition for reducing three highs |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN118577160A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108112973A (en) * | 2017-12-25 | 2018-06-05 | 大连深蓝肽科技研发有限公司 | A kind of auxiliary lower hyperlipidemia, hypertension, hyperglycemia composition and preparation method thereof |
| CN111149968A (en) * | 2018-11-08 | 2020-05-15 | 湖北铭泰健康科学有限公司 | Health solid beverage and preparation method thereof |
| CN112076269A (en) * | 2020-06-24 | 2020-12-15 | 王宇 | Auxiliary medicine for treating cardiovascular diseases |
| CN113057336A (en) * | 2021-04-15 | 2021-07-02 | 熊夜 | Nutritional composition for assisting in reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof |
| CN114522224A (en) * | 2022-01-22 | 2022-05-24 | 山东珠岳生物科技有限公司 | Effective blood pressure-reducing traditional Chinese medicine composition and preparation method thereof |
-
2023
- 2023-02-09 CN CN202410809372.2A patent/CN118577160A/en active Pending
- 2023-02-09 CN CN202310090587.9A patent/CN115944707A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108112973A (en) * | 2017-12-25 | 2018-06-05 | 大连深蓝肽科技研发有限公司 | A kind of auxiliary lower hyperlipidemia, hypertension, hyperglycemia composition and preparation method thereof |
| CN111149968A (en) * | 2018-11-08 | 2020-05-15 | 湖北铭泰健康科学有限公司 | Health solid beverage and preparation method thereof |
| CN112076269A (en) * | 2020-06-24 | 2020-12-15 | 王宇 | Auxiliary medicine for treating cardiovascular diseases |
| CN113057336A (en) * | 2021-04-15 | 2021-07-02 | 熊夜 | Nutritional composition for assisting in reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof |
| CN114522224A (en) * | 2022-01-22 | 2022-05-24 | 山东珠岳生物科技有限公司 | Effective blood pressure-reducing traditional Chinese medicine composition and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN118577160A (en) | 2024-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106819750A (en) | Hypoglycemic solid beverage of a kind of aided blood pressure-lowering and preparation method thereof | |
| CN102657329A (en) | Soluble tremella combination drink and preparation method thereof | |
| CN106860853A (en) | The diet-therapy health-preserving preparation of one class parting management fat | |
| CN102599311B (en) | Preparation method for grain health tea | |
| CN111227153A (en) | Dietary food for whitening, detoxifying and slimming | |
| CN105536970B (en) | A kind of Momordica grosvenori disintegrating apparatus | |
| CN115944707A (en) | Composition for reducing high blood pressure, high blood lipid and high blood sugar and preparation method thereof | |
| CN1098863A (en) | Prescription and method for prodn. of diabetes foodstuff | |
| CN101715995B (en) | Adlay-lotus root compound nutrient thick syrup and preparation method thereof | |
| CN109998010A (en) | A kind of full element solid beverage of plant | |
| CN114431455A (en) | Total nutrient composite fatty acid slimming functional food and preparation method thereof | |
| CN1245063A (en) | Tea for curing glycuresis and its making process | |
| CN1231900A (en) | Weight-loss medicine and its preparing method | |
| CN1947532A (en) | Soymilk powder contg. mother chrysanthemum | |
| CN1211393A (en) | Health-care tea beverage | |
| CN102907674A (en) | Solid beverage for tonifying Qi and strengthening heart and preparation method thereof | |
| CN1226952C (en) | Powdered food made from cactus and soy bean as main raw materials and processing method | |
| CN102511879A (en) | Thickened red jujube guiling jelly pulp | |
| CN212915342U (en) | Be applied to agitating unit of system pot of bamboo shoots | |
| CN1383759A (en) | Rhodiola beverage | |
| CN106135581A (en) | Weight-losing pasty herbal tea and preparation method thereof | |
| CN102885919A (en) | Preparation of slimming drug | |
| CN101467677A (en) | Health type beverage suitable for persons in middle and old age to drink | |
| CN1954698A (en) | Health-care food for regulating gastrointestinal tract function and its preparation process | |
| CN1907125B (en) | Red beet health food for radiotherapy and chemotherapy and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |